Glenn Whaley

This profile gathers the share dealings of Glenn Whaley across 2 companies, led by Immunic, Inc. and Pernix Therapeutics Holdings, Inc. Between 15 March 2018 and 3 June 2025, the trades on record add up to 11 filings.

The open-market record is one-sided, with 8 purchases worth €111k and not one sale. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Besides market trades, the filings include 3 share grants. Since January 2025: 1 purchase and no sales on the market.

Half of the purchases are above €13k and half below. Clusters matter here: 4 out of 8 purchases overlapped with buying by a colleague within 30 days. When several insiders buy within a few weeks of each other, analysts speak of a cluster purchase.

On 4 June 2025 came the latest disclosure, an open-market purchase for €28k in Immunic, Inc. The median gap between a trade and its publication by SEC (Form 4) is 1 day. For comparison, the SEC allows two business days to file a Form 4. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.